N Verses Capital, LLC Halozyme Therapeutics, Inc. Transaction History
N Verses Capital, LLC
- $41.7 Billion
- Q1 2024
A detailed history of N Verses Capital, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 1,800 shares of HALO stock, worth $99,270. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,800Holding current value
$99,270% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
452Shares Held
123MCall Options Held
216KPut Options Held
129K-
Black Rock Inc. New York, NY18.2MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$720 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$358 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$227 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$209 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.68B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...